• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制备细胞中间体EAC14的新方法。

New methods for the preparation of the cellular intermediate EAC14.

作者信息

Asghar S S, Out J

出版信息

J Immunol Methods. 1986 Dec 24;95(2):277-81. doi: 10.1016/0022-1759(86)90416-3.

DOI:10.1016/0022-1759(86)90416-3
PMID:3794347
Abstract

The cellular intermediate EAC14 was successfully prepared by incubating optimally sensitized sheep erythrocytes (EA) with normal serum diluted in complement diluent buffer containing suitable amounts of inhibitors of EAC142 formation from EAC14 and C2, namely polymyxin E and polymyxin B. EAC14 cells could also be prepared by incubating EA with normal serum diluted in Mg2+ free complement diluent buffer in the presence or absence of sucrose. The cellular intermediates prepared by these methods exhibited characteristic EAC142 formation and decay profiles and were found to be suitable for C2 estimations.

摘要

通过将最佳致敏绵羊红细胞(EA)与在含有适量EAC14和C2形成抑制剂(即多粘菌素E和多粘菌素B)的补体稀释缓冲液中稀释的正常血清孵育,成功制备了细胞中间体EAC14。EAC14细胞也可以通过在有或没有蔗糖存在的情况下,将EA与在无Mg2+补体稀释缓冲液中稀释的正常血清孵育来制备。通过这些方法制备的细胞中间体表现出特征性的EAC142形成和衰变曲线,并且发现适用于C2的估计。

相似文献

1
New methods for the preparation of the cellular intermediate EAC14.制备细胞中间体EAC14的新方法。
J Immunol Methods. 1986 Dec 24;95(2):277-81. doi: 10.1016/0022-1759(86)90416-3.
2
Simple method for preparing the cellular intermediate EAC14, and its use for estimation of the second component of complement.制备细胞中间体EAC14的简单方法及其在补体第二成分估计中的应用。
Clin Chem. 1986 Apr;32(4):678-9.
3
In vitro inhibition of the classical pathway of human complement by polymyxin B.
Biochem Pharmacol. 1987 Sep 15;36(18):2927-30. doi: 10.1016/0006-2952(87)90204-8.
4
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.经典途径激活的表面调节:绵羊、豚鼠和人红细胞上C2和C3转化酶的形成与调节
J Immunol. 1983 Jul;131(1):403-8.
5
Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.用含有分泌型补体成分C1至C3的巨噬细胞培养上清液形成EAC142和EAC1423。
Immunobiology. 1984 Mar;166(2):177-89. doi: 10.1016/s0171-2985(84)80036-4.
6
A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone.一种使用经甲基泼尼松龙处理的人血清制备EAC14中间细胞的简化方法。
J Immunol Methods. 1985 Dec 27;85(2):363-70. doi: 10.1016/0022-1759(85)90145-0.
7
In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.天然微生物产物硫酸黏菌素对人补体经典途径的体外抑制作用
Biochem Pharmacol. 1986 Sep 1;35(17):2917-21. doi: 10.1016/0006-2952(86)90486-7.
8
C1, C4, and C2 components of the classical pathway of complement and regulatory proteins.补体经典途径的C1、C4和C2成分以及调节蛋白。
Methods Enzymol. 1988;162:626-39. doi: 10.1016/0076-6879(88)62105-7.
9
EAC4 and EAC14 production without purified Ci.在没有纯化的Ci的情况下生产EAC4和EAC14。
J Immunol. 1975 Dec;115(6):1625-30.
10
Effect of concanavalin A on the classical complement pathway.
J Immunol. 1977 May;118(5):1622-5.